Drug/Insect/Latex News

Patients with stroke and inaccurate NSAID allergy labels had poorer outcomes including major adverse cardiovascular events, peripheral vascular disease and death, according to a study published in Stroke.

Patients who experience musculoskeletal pain have many pharmaceutical options for relief — unless they also suffer from allergies to these medications.

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is associated with a risk for anaphylaxis and issued a new boxed warning, according to a drug safety communication.

BOSTON — A history of NSAID-exacerbated respiratory disease may indicate increased risks for aspirin hypersensitivity, according to an abstract presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Healio has compiled November’s most read news in asthma and allergy.

BOSTON — Vaccine hesitancy was less likely to occur in racially diverse vs. white patients, although this hesitancy was not significantly impacted by age, sex or language, according to a poster presentation here.

ORLANDO — Delabeling inappropriate penicillin allergy labels in outpatient pediatric patients is feasible, according to an abstract presented at the American Academy of Pediatrics National Conference & Exhibition.

BOSTON — Physicians suspect the solvent used in the administration of pembrolizumab may have triggered recurrent angioedema for a patient with squamous cell carcinoma, according to a poster presented at the CHEST Annual Meeting.

Healio has compiled October’s most read news in asthma and allergy.